Parathyroid Allotransplant for Treatment of Hypoparathyroidism

Part of paid clinical trials in San Francisco, California.

Sponsor
Peter Stock
Study ID
NCT06961071
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Hypoparathyroidism
  • Hypoparathyroidism Post-surgical
  • Hypoparathyroidism Postprocedural

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Parathyroid Allotransplant — BIOLOGICAL
    Parathyroid Allotransplant

Study Details

This study is being done to see if transplanting parathyroid tissue into the forearm will help hypo-parathyroid patients achieve parathyroid hormone (PTH) levels that would help normalize their serum calcium and phosphorus levels. The parathyroid tissue used in this study will come from cadaveric tissues that were donated at the time of the death of the donor(s).

Key Dates

Start date
Jan 15, 2026
Status verified
Feb 2026
Primary completion
Jan 15, 2028
Completion
Jan 15, 2028

Study Design

Enrollment
3 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Parathyroid Allotransplant
    Parathyroid Allotransplant to treat hypoparathyroidism

Primary Outcome Measure

Levels of intact PTH [ Time Frame: From baseline to week 52 (year 1) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of California, San FranciscoSan FranciscoCalifornia94143
Crystal Loucel, MPH, MS, RN
[email protected]
415-476-3229

Find similar trials in San Francisco, CA

By research site
University of California, San Francisco· San Francisco, CA

Related Studies